FDA Warning Letter — Daniel Fred Goodman, M.D.

Case 634247 — FEI 3020460374

The FDA took a Warning Letter action against Daniel Fred Goodman, M.D. on Jul 19, 2022 (San Francisco, CA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Daniel Fred Goodman, M.D.
Date
Jul 19, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
San Francisco, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.